Percutaneous auricular neuromodulation (nerve stimulation) for the treatment of pain following cholecystectomy and hernia repair: a randomized, double-masked, sham-controlled pilot study
Authors' conclusion
Percutaneous auricular neuromodulation reduced pain scores but not opioid requirements during the initial week after cholecystectomy and hernia repair.
Study context
- Population
- Patients after cholecystectomy or hernia repair (ambulatory surgery)
- Participants
- 15 vs 15
- Comparison
- Percutaneous auricular neuromodulation vs sham for 5 days
- Active stimulationn = 15
- Shamn = 15reference
Methodological detailspilot, double-masked, sham-controlled
- Pilot
- Double-masked
- Sham-controlled
Primary result
As reported in the abstract
Pain level · first 5 days
Active stimulation
0.6
median · IQR 0.3–2.4
Sham
2.6
median · IQR 1.1–3.7
P = 0.041
Further findings
Severe pain (highest pain level) · entire 8-day study period
P = 0.031
Median, mg
| Outcome | Active stimulation | Sham | P value |
|---|---|---|---|
| Oxycodone use · first 5 days | 0 (IQR 0–1) | 0 (IQR 0–3) | P = 0.524 |
Original publication
Percutaneous auricular neuromodulation (nerve stimulation) for the treatment of pain following cholecystectomy and hernia repair: a randomized, double-masked, sham-controlled pilot study. Reg Anesth Pain Med. Published 21 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →